Welcome Guest | Register / Login

Healthcare Market Research Reports

Health care sector is perhaps the most critical of all sectors. The fact that would be an-ever increasing demand for health care globally makes this field most-sought-after. The demand for health care needs is often fuelled by newer, complex medical conditions, and more importantly growing population. Adding to these traditional reasons is the life-style changes that have become responsible for newer medical complications. While advancement in clinical R&D has considerably eased and helped in addressing the growing needs, inadequate clinical staff has been a major bane. Therefore, the health c... View more
Sort By
Title Published Price Buy Now
Accident & Emergency Partnering 2010-2015
By Current Partnering
Delivery of this report will take 1-3 days after purchase. Accident & Emergency Partnering 2009-2014 report provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading ...
May 2015 $ 995
Transplantation Partnering 2010-2015
By Current Partnering
Delivery of this report will take 1-3 days after purchase. Transplantation Partnering 2009-2014 report provides understanding and access to the transplantation partnering deals and agreements entered into by the worlds leading healthcare...
May 2015 $ 995
Veterinary Activities in Bulgaria - 2013
By SeeNews
Seenews Competitive Intelligence Veterinary Activities In Bulgaria - 2013 Provides You The Most Up-To-Date And Easy-To-Use Information In The Industry. Industry Report Covers: I. Landscape II. Employment - Number ...
Apr 2015 $ 340
Human Health Activities in Bulgaria - 2013
By SeeNews
Seenews Competitive Intelligence Human Health Activities In Bulgaria - 2013 Provides You The Most Up-To-Date And Easy-To-Use Information In The Industry. Industry Report Covers: I. Landscape II. Employment - Numbe...
Apr 2015 $ 340
Residential Care Activities in Bulgaria - 2013
By SeeNews
Seenews Competitive Intelligence Residential Care Activities In Bulgaria - 2013 Provides You The Most Up-To-Date And Easy-To-Use Information In The Industry. Industry Report Covers: I. Landscape II. Employment - N...
Apr 2015 $ 340
Australia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Recent attempts by the Australian government to introduce cost saving changes to the Medicare program have been met with opposition. Most have now been shelved. With healthcare costs growing at a 'rapid and unsustainable rate', ...
Apr 2015 $ 1295
Bangladesh Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The gap in the provision of medical services in Bangladesh provides a strong business opportunity for private healthcare providers to make a foray into the market and establish a first mover advantage. This is further affirmed b...
Apr 2015 $ 1295
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Despite Cambodia's aim towards universal health coverage, we highlight that financial sustainability will remain a key issue. Nevertheless we highlight that pharmaceutical firms will benefit from this. Headline Expenditure...
Apr 2015 $ 1295
India Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: India's challenging intellectual property landscape will continue to drive innovative drugmakers to adopt risk mitigation strategies, including forming partnerships with Indian generic pharmaceuticals companies. We highlight tha...
Apr 2015 $ 1295
Indonesia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Generic drugs sales in Indonesia will continue to see significant growth as they remain favoured by both low per capita pharmaceutical spending and inadequate intellectual property protection in the country. This is further rein...
Apr 2015 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: While the persistence of lower oil prices will drive down national budgets and curtail some investment programmes, we maintain that the healthcare sector's perception as a critical source of economic diversification away from hy...
Apr 2015 $ 1295
Lithuania Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The deteriorating macro outlook for Russia will impact Lithuania's economy, with negative effects on fiscal planning and therefore the pharmaceutical and healthcare sectors. However, the centre-left government's partial reversal...
Apr 2015 $ 1295
South Africa Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The continued commitment of the South African government to boosting spending on healthcare will be the primary driver for the growth of the pharmaceutical market in 2015. Although lower oil prices will improve the consumer envi...
Apr 2015 $ 1295
Switzerland Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Switzerland's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, the burden of chronic conditions ...
Apr 2015 $ 1295
Uganda Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Communicable diseases result in a high mortality rate in Uganda, which is reflected in the latest outbreak of typhoid fever. However, tackling the acute shortage of healthcare professionals to deal with diseases such as typhoid ...
Apr 2015 $ 1295
Venezuela Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Venezuela's pursuit of autonomy in pharmaceutical production and its overall pharmaceutical market will continue to diminish its appeal for foreign drugmakers. As the country deals with one of the worst performing currencies in ...
Apr 2015 $ 1295
Egypt Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Egypt's inclusion on PhRMA's Special 301 Submission for the second year running highlights that regulatory approval delays and a restrictive pricing policy are still issues being faced by innovative drugmakers operating in the c...
Apr 2015 $ 1295
Iran Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. Despite not specifically targeting medicines, sanctions against Iran had dir...
Apr 2015 $ 1295
Malaysia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Commercial opportunities for private healthcare providers in Malaysia will be buoyed by the robust growth in the country's medical tourism industry. Driven by strong demand from Asia and the weakening currency, we highlight that...
Apr 2015 $ 1295
Moldova Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: While short-term prospects for the Moldovan pharmaceutical market present limited opportunities for investors, long term opportunities in the region show great potential. With Moldovan relationships strengthening between China a...
Apr 2015 $ 1295
Morocco Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: A new wave of drug price cuts in Morocco and the implementation of the final stage of its universal healthcare coverage programme will see an improvement in the population's access to medicines. While increasing access to medici...
Apr 2015 $ 1295
Slovakia Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: In 2014, almost 2.47% of the country's GDP was spent on pharmaceuticals, as combined sales of prescription drugs and over-the-counter medicines - sold through pharmacies and hospitals at consumer prices - reached EUR1.85bn (USD2...
Apr 2015 $ 1295
Spain Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: The Spanish economy has exited the crisis stage and will post relatively strong real GDP growth rates compared to most other major eurozone economies over the next few years. However, we believe government spending will have a n...
Apr 2015 $ 1295
Taiwan Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical and healthcare investment, but is not without flaws. Weaknesses in the country's regulatory regime and drug pricing concerns will continu...
Apr 2015 $ 1295
Turkey Pharmaceuticals and Healthcare Report Q2 2015
By Business Monitor International
BMI View: Turkey possesses all the key growth fundamentals for an attractive pharmaceutical sector, but heavy regulatory oversight will stifle growth over the short term. Over the longer term, we expect the regulatory burden to lessen and...
Apr 2015 $ 1295
Live Chat
Live Chat by Comm100